518 related articles for article (PubMed ID: 18830669)
61. Comparison between established and the Worldwide Esophageal Cancer Collaboration staging systems.
Gaur P; Hofstetter WL; Bekele BN; Correa AM; Mehran RJ; Rice DC; Roth JA; Vaporciyan AA; Rice TW; Swisher SG
Ann Thorac Surg; 2010 Jun; 89(6):1797-1803, 1804.e1-3; discussion 1803-4. PubMed ID: 20494031
[TBL] [Abstract][Full Text] [Related]
62. Predicting systemic disease in patients with esophageal cancer after esophagectomy: a multinational study on the significance of the number of involved lymph nodes.
Peyre CG; Hagen JA; DeMeester SR; Van Lanschot JJ; Hölscher A; Law S; Ruol A; Ancona E; Griffin SM; Altorki NK; Rice TW; Wong J; Lerut T; DeMeester TR
Ann Surg; 2008 Dec; 248(6):979-85. PubMed ID: 19092342
[TBL] [Abstract][Full Text] [Related]
63. Survival and prognostic factors in patients with resected epidermoid oesophageal carcinoma.
Rosa AR; Gurski RR; Schirmer CC; Brentano L; Kruel CD
Int Surg; 1999; 84(3):193-8. PubMed ID: 10533775
[TBL] [Abstract][Full Text] [Related]
64. [Results of surgical therapy of esophageal carcinoma in a general hospital].
Aleksic M; Wolf B; Ulrich B
Chirurg; 1995 Dec; 66(12):1247-53. PubMed ID: 8582170
[TBL] [Abstract][Full Text] [Related]
65. Inflammation-based prognostic score, prior to neoadjuvant chemoradiotherapy, predicts postoperative outcome in patients with esophageal squamous cell carcinoma.
Kobayashi T; Teruya M; Kishiki T; Endo D; Takenaka Y; Tanaka H; Miki K; Kobayashi K; Morita K
Surgery; 2008 Nov; 144(5):729-35. PubMed ID: 19081014
[TBL] [Abstract][Full Text] [Related]
66. Prognostic value and clinical relevance of the 6th Edition 2002 American Joint Committee on Cancer staging system in patients with resectable hepatocellular carcinoma.
Lei HJ; Chau GY; Lui WY; Tsay SH; King KL; Loong CC; Wu CW
J Am Coll Surg; 2006 Oct; 203(4):426-35. PubMed ID: 17000385
[TBL] [Abstract][Full Text] [Related]
67. How many lymph nodes are needed for an accurate pN classification in esophageal cancer? Evidence for a new threshold value.
Dutkowski P; Hommel G; Böttger T; Schlick T; Junginger T
Hepatogastroenterology; 2002; 49(43):176-80. PubMed ID: 11941947
[TBL] [Abstract][Full Text] [Related]
68. Lymph node analysis in esophageal resection: American College of Surgeons Oncology Group Z0060 trial.
Veeramachaneni NK; Zoole JB; Decker PA; Putnam JB; Meyers BF;
Ann Thorac Surg; 2008 Aug; 86(2):418-21; discussion 421. PubMed ID: 18640307
[TBL] [Abstract][Full Text] [Related]
69. [Differentiated surgical therapy of esophageal carcinoma].
Junginger T; Dutkowski P; Böttger T; Wahl W
Chirurg; 1995 Jul; 66(7):693-703. PubMed ID: 7545571
[TBL] [Abstract][Full Text] [Related]
70. Local recurrence after total or subtotal esophagectomy for esophageal cancer.
Blewett CJ; Miller JD; Ramlawi B; Young JE; BennettWF ; Urschel JD
J Exp Clin Cancer Res; 2001 Mar; 20(1):17-9. PubMed ID: 11370823
[TBL] [Abstract][Full Text] [Related]
71. Prediction of lymph node status in superficial esophageal carcinoma.
Ancona E; Rampado S; Cassaro M; Battaglia G; Ruol A; Castoro C; Portale G; Cavallin F; Rugge M
Ann Surg Oncol; 2008 Nov; 15(11):3278-88. PubMed ID: 18726651
[TBL] [Abstract][Full Text] [Related]
72. The prognostic importance of the number of involved lymph nodes in esophageal cancer: implications for revisions of the American Joint Committee on Cancer staging system.
Rizk N; Venkatraman E; Park B; Flores R; Bains MS; Rusch V;
J Thorac Cardiovasc Surg; 2006 Dec; 132(6):1374-81. PubMed ID: 17140960
[TBL] [Abstract][Full Text] [Related]
73. Comparison of the 6th and 7th Editions of the UICC-AJCC TNM Classification for Esophageal Cancer.
Talsma K; van Hagen P; Grotenhuis BA; Steyerberg EW; Tilanus HW; van Lanschot JJ; Wijnhoven BP
Ann Surg Oncol; 2012 Jul; 19(7):2142-8. PubMed ID: 22395974
[TBL] [Abstract][Full Text] [Related]
74. Prognostic relevance of histomorphological parameters and DNA content and their therapeutic consequences in esophageal carcinoma: a multivariate approach.
Boettger T; Dutkowski P; Kirkpatrick CJ; Seifert JK; Junginger T
Hepatogastroenterology; 1998; 45(22):994-1004. PubMed ID: 9755996
[TBL] [Abstract][Full Text] [Related]
75. En bloc esophagectomy reduces local recurrence and improves survival compared with transhiatal resection after neoadjuvant therapy for esophageal adenocarcinoma.
Rizzetto C; DeMeester SR; Hagen JA; Peyre CG; Lipham JC; DeMeester TR
J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1228-36. PubMed ID: 18544359
[TBL] [Abstract][Full Text] [Related]
76. Improved prediction of recurrence after curative resection of colon carcinoma using tree-based risk stratification.
Radespiel-Tröger M; Hohenberger W; Reingruber B
Cancer; 2004 Mar; 100(5):958-67. PubMed ID: 14983491
[TBL] [Abstract][Full Text] [Related]
77. Ten-year survival of esophageal cancer after an en-bloc esophagectomy.
Oezcelik A; Kaiser GM; Niebel W; Sleyman C; Treckmann JW; Sotiropoulos GC; Reinhardt R; Trarbach T; Malamutmann E; Paul A
J Surg Oncol; 2012 Mar; 105(3):284-7. PubMed ID: 21953648
[TBL] [Abstract][Full Text] [Related]
78. Significant variation of resected meso-esophageal tissue volume in two-stage subtotal esophagectomy specimens: a retrospective morphometric study.
Izon AS; Jose P; Hayden JD; Grabsch HI
Ann Surg Oncol; 2013 Mar; 20(3):788-97. PubMed ID: 22983387
[TBL] [Abstract][Full Text] [Related]
79. Adenocarcinoma of the gastroesophageal junction: influence of esophageal resection margin and operative approach on outcome.
Barbour AP; Rizk NP; Gonen M; Tang L; Bains MS; Rusch VW; Coit DG; Brennan MF
Ann Surg; 2007 Jul; 246(1):1-8. PubMed ID: 17592282
[TBL] [Abstract][Full Text] [Related]
80. En bloc vs transhiatal esophagectomy for stage T3 N1 adenocarcinoma of the distal esophagus.
Johansson J; DeMeester TR; Hagen JA; DeMeester SR; Peters JH; Oberg S; Bremner CG
Arch Surg; 2004 Jun; 139(6):627-31; discussion 631-3. PubMed ID: 15197089
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
